Stanniocalcin-2
US6171822A · kind A · utility
2Cited by
1References
7Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 11, 1999 |
| Grant date | Jan 9, 2001 |
| Priority date | — |
| Expiry date | Oct 11, 2019 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K14/575
- WIPO fieldBiotechnology
- WIPO sectorChemistry
Abstract
The present invention relates to polynucleotide and polypeptide molecules for stanniocalcin-2, a novel member of the stanniocalcin family. The polypeptides, and polynucleotides encoding them, modulate electrolyte homeostasis. The present invention also includes antibodies to the stanniocalcin-2 polypeptides.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.